Status:

COMPLETED

Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers

Lead Sponsor:

Ironwood Pharmaceuticals, Inc.

Conditions:

Healthy Volunteers

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

The primary objectives of this study are the following: * To evaluate the pharmacokinetics (PK) of a monophasic oral contraceptive's active components, ethinyl estradiol (EE) and norethindrone acetat...

Eligibility Criteria

Inclusion

  • Is healthy, ambulatory, and 18-50 years of age (inclusive) at screening visit.
  • Weighs at least 50 kg and has a body mass index within 18-35 kg/m2 at the screening visit.
  • Is not pregnant or breastfeeding at the time of the screening visit and has negative serum pregnancy tests at the screening visit and check-in.
  • Other inclusion criteria per protocol.

Exclusion

  • Has used any prescription drugs, herbal supplements, over-the-counter medication, or dietary supplements (vitamins included) within 4 weeks prior to dosing. If needed, (ie, incidental and limited need), acetaminophen is acceptable.
  • Has consumed grapefruit or grapefruit juice within 4 weeks prior to dosing or plans to consume grapefruit or grapefruit juice before 7 days following the last dose.
  • Has a significant illness that has not resolved within 2 weeks prior to dosing.
  • Has a history of immunodeficiency diseases, including a positive human immunodeficiency virus test result.
  • Has a positive hepatitis B surface antigen or hepatitis C antibody test result.
  • Is a smoker or has used nicotine or nicotine-containing products (eg, snuff, nicotine patch, nicotine chewing gum, mock cigarettes, or inhalers) within 6 months before the first dose of study drug.
  • Other exclusion criteria per protocol.

Key Trial Info

Start Date :

March 11 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 3 2019

Estimated Enrollment :

87 Patients enrolled

Trial Details

Trial ID

NCT03856970

Start Date

March 11 2019

End Date

July 3 2019

Last Update

July 29 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

PPD

Austin, Texas, United States, 78744